Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-11-041370
Filing Date
2011-08-12
Accepted
2011-08-12 10:28:08
Documents
1
Period of Report
2011-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3602
  Complete submission text file 0001140361-11-041370.txt   4990
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address REPLIGEN CORPORATION 41 SEYON ST WALTHAM MA 02453
Business Address
Goldberg Alfred Lewis (Reporting) CIK: 0001438947 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 111029622